|
NDUFA11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.089230E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.979900E-02 |
| Normal-vs-Stage2 |
1.527790E-01 |
| Normal-vs-Stage3 |
9.923700E-02 |
| Normal-vs-Stage4 |
9.504000E-01 |
| Stage1-vs-Stage2 |
7.699000E-01 |
| Stage1-vs-Stage3 |
8.532200E-01 |
| Stage1-vs-Stage4 |
1.834430E-02 |
| Stage2-vs-Stage3 |
8.858400E-01 |
| Stage2-vs-Stage4 |
1.321410E-01 |
| Stage3-vs-Stage4 |
6.510000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.442180E-01 |
| Normal-vs-AfricanAmerican |
6.367600E-01 |
| Normal-vs-Asian |
7.107900E-02 |
| Caucasian-vs-AfricanAmerican |
5.648800E-01 |
| Caucasian-vs-Asian |
4.916400E-01 |
| AfricanAmerican-vs-Asian |
3.090800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.189640E-01 |
| Normal-vs-Female |
1.240820E-01 |
| Male-vs-Female |
9.200200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.642300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.497350E-01 |
| Normal-vs-Age(61-80Yrs) |
4.569600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.977400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.298200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.410160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.655800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.556000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.599000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.193600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.992800E-01 |
| Classical-VS-Follicular |
2.601600E-02 |
| Classical-VS-Other |
4.076600E-01 |
| Classical-VS-Normal |
2.860000E-01 |
| Tall-VS-Follicular |
2.209600E-01 |
| Tall-VS-Other |
5.991200E-01 |
| Tall-VS-Normal |
5.464600E-01 |
| Follicular-VS-Other |
4.518800E-01 |
| Follicular-VS-Normal |
9.041800E-03 |
| Other-VS-Normal |
1.507640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.984000E-03 |
| Normal-vs-N1 |
1.691760E-01 |
| N0-vs-N1 |
5.115200E-01 |
|
|
